HEMATOGENIX LABORATORY SERVICES

HEMATOGENIX LABORATORY SERVICES is neither a factory nor a trader. It is a specialized laboratory and a contract research organization (CRO) providing advanced diagnostic and research services.

Company Introduction:

HEMATOGENIX LABORATORY SERVICES is a global contract research organization (CRO) with a significant presence in Malaysia, dedicated to providing highly specialized central laboratory services for oncology clinical trials. The company plays a crucial role in supporting pharmaceutical and biotechnology companies by offering a comprehensive suite of diagnostic and prognostic testing services essential for drug development, particularly in the field of cancer research.

Their core offerings include advanced immunohistochemistry, flow cytometry, molecular assays, cytogenetics, and biorepository services. These specialized tests are vital for biomarker identification, patient stratification, assessing drug efficacy, and supporting regulatory submissions for novel cancer therapies. The Malaysian facility operates as a strategic hub within Hematogenix's global network, extending its expertise and capabilities to facilitate clinical trials across the Asia-Pacific region. The company is committed to delivering high-quality, consistent, and reliable laboratory results, thereby contributing significantly to the advancement of oncology research and precision medicine.

Hematogenix Laboratory Services in Malaysia primarily offers specialized testing services for hematological malignancies. They do not manufacture or sell physical products. Their main offerings include:

* **Flow Cytometry:** Immunophenotyping for leukemia, lymphoma, and myeloma.

* **Cytogenetics:** Chromosome analysis for hematologic disorders.

* **Molecular Diagnostics:** Genetic testing for mutations and gene expression analysis.

* **Anatomic Pathology:** Bone marrow biopsies and pathology review.